RESUMEN
This study investigates the effects of mistletoe lectin-I (ML-I) on melanoma growth and spread in vivo. The human melanoma cell line MV3 was xenografted into severe combined immunodeficient mice and vehicle solution or purified ML-I was administered at 30, 150 and 500 ng per kg body weight (20 mice per group) daily. After 19 days, mice were killed, primary tumours (PTs) and lungs were dissected out, and tumour weights, number of lung metastases (LMs), number of tumour-infiltrating dendritic cells (DCs), and apoptosis rates in the melanoma cells and in the DCs were assessed. A 35% reduction of PT weight (P=0.03) and a 55% decrease in number of LMs (P=0.016) were evident for low-dose ML-I (30 ng kg(-1)) treatment but not for higher doses. Mistletoe lectin-I increased apoptosis rates in the melanoma cells of PTs at all doses, while no induction of apoptosis was noted in the LMs. Low-dose ML-I significantly increased the number of DCs infiltrating the PTs (P<0.0001) and protected DCs against apoptosis, while higher doses induced apoptosis in the DCs (P<0.01). Our results demonstrate that low-dose ML-I reduced melanoma growth and number of metastases in vivo, primarily due to immunomodulatory effects.
Asunto(s)
Apoptosis/efectos de los fármacos , Neoplasias Pulmonares/tratamiento farmacológico , Melanoma Experimental/tratamiento farmacológico , Preparaciones de Plantas/administración & dosificación , Proteínas de Plantas/administración & dosificación , Proteínas Inactivadoras de Ribosomas Tipo 2/administración & dosificación , Toxinas Biológicas/administración & dosificación , Animales , Células Dendríticas/efectos de los fármacos , Células Dendríticas/metabolismo , Células Dendríticas/patología , Humanos , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/secundario , Linfocitos Infiltrantes de Tumor , Masculino , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Ratones , Ratones Endogámicos BALB C , Ratones SCID , Trasplante Heterólogo , Células Tumorales CultivadasRESUMEN
Plant lectins are under consideration as targeting agents to enhance the efficacy of orally administered drugs and vaccines. A significant issue that must be considered is the immunogenicity of these molecules since an immune response to the targeting agent may interfere with its ability to interact with the epithelium. In contrast, the ability of certain lectins to activate the immune system may be exploited in the delivery of vaccines. We previously demonstrated that plant lectins vary widely in their immunogenicity and in particular that mistletoe lectins (ML) I, II and II (MLI, MLII, MLIII) are potent immunogens when administered nasotracheally. Here, we measured immune responses following oral delivery of the MLs and assessed their ability to enhance responses to a co-administered antigen to determine if the molecules possess adjuvant activity. Oral administration of the lectins induced potent lectin-specific systemic and mucosal antibody responses. In addition, each of the three lectins possessed adjuvant activity when delivered orally together with ovalbumin (OVA). The lectins enhanced both serum and mucosal antibody responses to the co-delivered antigen. This shows for the first time that MLI, MLII and MLIII possess adjuvant activity when administered orally and may provide a platform for the generation of effective mucosal adjuvants.
Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Tracto Gastrointestinal/inmunología , Lectinas de Plantas/inmunología , Vacunas/administración & dosificación , Administración Oral , Animales , Femenino , Inmunoglobulina G/inmunología , Inmunoglobulina G/aislamiento & purificación , Ratones , Ratones Endogámicos BALB C , Lectinas de Plantas/administración & dosificación , Preparaciones de Plantas/inmunología , Proteínas de Plantas/inmunología , Proteínas Inactivadoras de Ribosomas , Proteínas Inactivadoras de Ribosomas Tipo 2 , Toxinas Biológicas/inmunologíaRESUMEN
The mucosal adjuvant properties of the three type 2 ribosome-inactivating proteins (RIPs) from the European mistletoe, Viscum album L., were investigated. Mistletoe lectins were compared with cholera toxin (CT) as adjuvants when delivered nasotracheally together with herpes simplex virus glycoprotein D2 (gD2). All three mistletoe lectins (MLI, MLII, MLIII) were potent mucosal adjuvants. Co-administration of MLI, MLII or MLIII with gD2 led to significantly higher levels of gD2-specific mucosal immunoglobulin A (IgA) and systemic immunoglobulin G (IgG) antibody than when the antigen was delivered alone. The levels of antibodies induced were similar to those generated in mice immunized with gD2 and the potent mucosal adjuvant CT. Administration of ML1 with gD2 enhanced the antigen-specific splenic T-cell proliferative response. Interleukin-5 (IL-5), but not interferon-gamma (IFN-gamma), was detected in supernatants from splenocytes stimulated in vitro with gD2. This indicates that MLI enhanced type 2 T-helper cell (Th2) responses to the bystander antigen, gD2. Analysis of the gD2- and lectin-specific IgG subclass titres in mice immunized with gD2 and MLI, MLII or MLIII revealed a high ratio of IgG1 : IgG2a, which is compatible with the selective induction of Th2-type immune responses.
Asunto(s)
Adyuvantes Inmunológicos , Vacunas contra el Virus del Herpes Simple/inmunología , Lectinas de Plantas/inmunología , Preparaciones de Plantas/inmunología , Proteínas de Plantas , Toxinas Biológicas/inmunología , Proteínas del Envoltorio Viral/inmunología , Administración Intranasal , Animales , Anticuerpos Antivirales/biosíntesis , División Celular/inmunología , Citocinas/biosíntesis , Femenino , Inmunidad Mucosa , Inmunización/métodos , Inmunoglobulina A/biosíntesis , Inmunoglobulina G/biosíntesis , Ratones , Ratones Endogámicos BALB C , Muérdago/inmunología , Proteínas Inactivadoras de Ribosomas Tipo 2 , Linfocitos T Colaboradores-Inductores/inmunologíaRESUMEN
BACKGROUND: Glycoconjugates, as detected by lectin histochemistry, have been implicated in metastasis formation in many neoplasias. However, no data concerning the three mistletoe lectins (MLs) and the spread of malignant melanoma have been published. MATERIALS AND METHODS: The binding status of ML-I, -II and -III was histochemically assessed in 100 malignant melanomas and correlated with metastasis in a 10 year follow-up period. Furthermore, the staining intensity of the three MLs, scored from negative (-) to very intense (+ + +), was evaluated. RESULTS: Kaplan-Meier analsis revealed that very intense binding (+ + +) of ML-I was positively-correlated with metastasis (p=0.044). CONCLUSION: Since ML-I is specific for galactose, high density galactose expression in malignant melanoma is a predictor of poor prognosis.
Asunto(s)
Antineoplásicos Fitogénicos/metabolismo , Lectinas/metabolismo , Melanoma/metabolismo , Preparaciones de Plantas , Proteínas de Plantas , Neoplasias Cutáneas/metabolismo , Toxinas Biológicas/metabolismo , Adyuvantes Inmunológicos/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/patología , Tablas de Vida , Masculino , Melanoma/patología , Melanoma/cirugía , Persona de Mediana Edad , Metástasis de la Neoplasia , Pronóstico , Proteínas Inactivadoras de Ribosomas Tipo 2 , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía , Toxinas Biológicas/farmacologíaRESUMEN
A mixture of two mistletoe lectins (MLs) has been separated according to the degree of glycosylation using boronate affinity chromatography. The mistletoe lectins, mistletoe lectin I (MLI) and mistletoe lectin III (MLIII) with degrees of glycosylation of 6.1 and 3.8%, respectively, were used in the investigation. MLI exhibited a higher retention time than MLIII due to its higher degree of glycosylation. Separation was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The developed method may lead to new applications for the boronate affinity technique, as well as provide an alternative separation method for MLs.
Asunto(s)
Ácidos Borónicos/química , Cromatografía de Afinidad/métodos , Preparaciones de Plantas , Proteínas de Plantas , Toxinas Biológicas/aislamiento & purificación , Electroforesis en Gel de Poliacrilamida , Glicosilación , Proteínas Inactivadoras de Ribosomas Tipo 2 , Sefarosa , Toxinas Biológicas/químicaRESUMEN
To date, the most potent mucosal vaccine adjuvants to be identified have been bacterial toxins. The present data demonstrate that the type 2 ribosome-inactivating protein (type 2 RIP), mistletoe lectin I (ML-I) is a strong mucosal adjuvant of plant origin. A number of plant lectins were investigated as intranasal (i.n.) coadjuvants for a bystander protein, ovalbumin (OVA). As a positive control, a potent mucosal adjuvant, cholera toxin (CT), was used. Co-administration of ML-I or CT with OVA stimulated high titres of OVA-specific serum immunoglobulin G (IgG) in addition to OVA-specific IgA in mucosal secretions. CT and ML-I were also strongly immunogenic, inducing high titres of specific serum IgG and specific IgA at mucosal sites. None of the other plant lectins investigated significantly boosted the response to co-administered OVA. Immunization with phytohaemagglutinin (PHA) plus OVA elicited a lectin-specific response but did not stimulate an enhanced response to OVA compared with the antigen alone. Intranasal delivery of tomato lectin (LEA) elicited a strong lectin-specific systemic and mucosal antibody response but only weakly potentiated the response to co-delivered OVA. In contrast, administration of wheatgerm agglutinin (WGA) or Ulex europaeus lectin 1 (UEA-I) with OVA stimulated a serum IgG response to OVA while the lectin-specific responses (particularly for WGA) were relatively low. Thus, there was not a direct correlation between immunogenicity and adjuvanticity although the strongest adjuvants (CT, ML-I) were also highly immunogenic.
Asunto(s)
Adyuvantes Inmunológicos , Inmunidad Mucosa , Inmunoglobulina A Secretora/biosíntesis , Lectinas/inmunología , Preparaciones de Plantas , Proteínas de Plantas , Animales , Toxina del Cólera/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Inmunización , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/sangre , Ratones , Ratones Endogámicos BALB C , Ovalbúmina/inmunología , Proteínas Inactivadoras de Ribosomas Tipo 2 , Toxinas Biológicas/inmunologíaRESUMEN
BACKGROUND: Immunological reactivity is regulated by T-cell populations (type-1 and type-2 cells) via cytokine secretion, but their influence on apoptosis remains unclear. METHODS: Intracellular expression of type-1 (interferon [IFN]-gamma) and type-2 (interleukin [IL]-4) cytokines and apoptosis-related molecules (Apo2. 7, Bcl-2 protein) was studied by flow cytometry in human peripheral blood mononuclear cells (PBMC), myeloma (U-266), monocytic (THP-1), and T-leukemia cells (MOLT-4) in response to toxins, which act on different intracellular targets (actinomycin D, cycloheximide, the mistletoe lectins [ML]-1 and ML-3, brefeldin A, staurosporine). RESULTS: The apoptosis-inducing toxins stimulated intracellular IL-4 expression mainly in PBMC with high expression of the mitochondrial apoptosis marker, Apo2.7, but with decreased level of the anti-apoptotic Bcl-2 protein. Up-regulation of IL-4 coincided with a significant down-regulation of IFN-gamma in CD4(+) and CD8(+) cells. The inhibitor of oxidative phosphorylation, oligomycin, and the caspase inhibitor, z-VAD-fmk, abolished IL-4 expression and DNA fragmentation in the PBMC. Also in the myeloma, monocytic, and T-leukemia cells, IL-4 was mainly observed in the Apo2.7(+) apoptotic cells in response to the toxins. CONCLUSIONS: We suggest that the different apoptotic toxins activate a common pathway in which IL-4 production plays a yet unknown intracellular role further downstream during apoptosis.
Asunto(s)
Apoptosis/efectos de los fármacos , Interleucina-4/metabolismo , Preparaciones de Plantas , Proteínas de Plantas , Linfocitos T/efectos de los fármacos , Toxinas Biológicas/farmacología , Brefeldino A/farmacología , Linfocitos T CD4-Positivos/citología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/citología , Linfocitos T CD8-positivos/efectos de los fármacos , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Inhibidores de Caspasas , Caspasas/metabolismo , Células Cultivadas , Cicloheximida/farmacología , Fragmentación del ADN/efectos de los fármacos , Dactinomicina/farmacología , Inhibidores Enzimáticos/farmacología , Citometría de Flujo , Humanos , Etiquetado Corte-Fin in Situ , Interferón gamma/biosíntesis , Interferón gamma/metabolismo , Interferón gamma/farmacología , Interleucina-4/biosíntesis , Interleucina-4/inmunología , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Fosforilación Oxidativa/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteínas Inactivadoras de Ribosomas Tipo 2 , Estaurosporina/farmacología , Linfocitos T/citología , Linfocitos T/inmunología , Linfocitos T/metabolismo , Células Tumorales CultivadasRESUMEN
BACKGROUND: Extracts from European mistletoe are used for adjuvant cancer treatment. Their influence on the intracellular expression of cytokines of the T-helper cells type-1 (Th1; IFN-gamma) or type-2 (Th2; IL-4) is still unknown. MATERIALS AND METHODS: Lymphocytes from controls were incubated with mistletoe extracts (ME) and mistletoe lectins (ML) for 24 hours and co-stimulated with PMA/Ca-ionophore/monensin during the last 6 hours. Apoptosis and intracellular cytokine expression were detected by flow cytometry, the cytokine release into the supernatants by ELISA. RESULTS: ME and ML significantly inhibited intracellular expression of IFN-gamma but stimulated IL-4. Thereby, IL-4 was mainly expressed in apoptotic (Apo2.7+) cells. However, IFN-gamma secretion into the supernatants of the cells was dose-dependently inhibited by ME and ML, while IL-4 was not detected at all. CONCLUSION: The intracellular expression of the 'Th2-cytokine' IL-4 in ME- and ML-exposed cells may not be related to a typical Th2-response but rather to cell death. This effect might be of great relevance e.g. after intratumoural injection of the mistletoe extracts and, in general, for the inhibition of an inflammatory response during apoptosis.
Asunto(s)
Apoptosis , Interferón gamma/antagonistas & inhibidores , Interleucina-4/biosíntesis , Muérdago , Plantas Medicinales , Células Cultivadas , Regulación hacia Abajo , Europa (Continente) , Interferón gamma/metabolismo , Líquido Intracelular/inmunología , Leucocitos Mononucleares/citología , Muérdago/química , Extractos Vegetales/farmacologíaRESUMEN
A special microfiltrated colloidal preparation from fresh Viscum album L. berries was investigated concerning the occurrence and structural features of polymeric carbohydrates. A crude polysaccharide fraction was isolated from lectin-, tannin- and protein-depleted microfiltrates. Further fractionation by exchange chromatography revealed a neutral fraction (average molecular weight 30 kDa) and three acidic fractions (average molecular weights 1300 kDa). Structural analysis of the respective polysaccharide fractions by quantitative and qualitative determination of the sugar composition and linkage analysis indicated that all acidic fractions contained an acidic arabinogalactan with a rhamnose-galactoronic acid backbone and highly branched arabinose-galactose side chains attached by the rhamnose residues to the backbone. The neutral fraction consisted of a neutral arabinogalactan beside minor amounts (about 10%) of a low substituted xyloglucan. Further studies on interaction between the 1340 kDa acidic rhamno-arabinogalactans II and III and mistletoe lectin Viscum album agglutinin I (VAA I) revealed binding capacities between these compounds, while the neutral polymers interacted significantly less with VAA I. Only partial binding of VAA I was observed by incubation of the lectin with polysaccharide II. Similar interactions of polysaccharide fraction III with VAA I was measured in a BIACRORE biosensore system. Using the hemagglutination test, increased agglutination of erythrocytes was observed when mistletoes lectin I and the respective polysaccharide fractions were present together in the assay. All these data indicate clearly strong interaction between VAA I and Viscum polysaccharides.
Asunto(s)
Muérdago/química , Preparaciones de Plantas , Proteínas de Plantas , Plantas Medicinales , Polisacáridos/farmacología , Toxinas Biológicas/farmacología , Adulto , Cromatografía de Gases , Cromatografía Líquida de Alta Presión , Hemaglutinación/efectos de los fármacos , Humanos , Técnicas In Vitro , Lectinas , Masculino , Metilación , Persona de Mediana Edad , Peso Molecular , Extractos Vegetales/química , Lectinas de Plantas , Polisacáridos/química , Proteínas Inactivadoras de Ribosomas , Proteínas Inactivadoras de Ribosomas Tipo 2 , Espectrofotometría Ultravioleta , Toxinas Biológicas/químicaRESUMEN
BACKGROUND: Mistletoe lectins (ML), the major biologically active components of mistletoe extracts, which are used for adjuvant cancer therapy, induce apoptosis in lymphocytes and tumor cells. In addition, ML at toxic concentrations induce the release of cytokines, but it remains unclear as to whether dying or activated cells are responsible. MATERIALS AND METHODS: By flow cytometry, expression of IFN-gamma, IL-4, apoptosis marker Apo2.7 and anti-apoptotic Bcl-2 proteins were analyzed in response to ML or viscotoxins (VT) in PBMC from controls and plasmocytoma cells (U-266). RESULTS: While ML inhibited PMA/Ca-ionophore/monensin co-stimulated IFN-gamma production, they increased IL-4 expression in CD8+ and CD4+ T-cells. Thereby, IL-4 was mainly expressed in apoptotic cells with a low level of Bcl-2 proteins. In contrast, the cell membrane permeabilising VT induced complete loss of Bcl-2 proteins but did not stimulate IL-4 production within 24 hours, indicating that IL-4 expression is related to apoptosis but not to necrosis. CONCLUSION: Despite the role of IL-4 during activation of type2 T-helper cells, IL-4 expression may play an important yet undefined role during apoptosis of normal and tumor cells.
Asunto(s)
Apoptosis , Interferón gamma/metabolismo , Interleucina-4/metabolismo , Muérdago/toxicidad , Preparaciones de Plantas , Proteínas de Plantas , Plantas Medicinales , Toxinas Biológicas/toxicidad , Citometría de Flujo , Expresión Génica/efectos de los fármacos , Humanos , Muérdago/química , Plasmacitoma/metabolismo , Plasmacitoma/patología , Proteínas Inactivadoras de Ribosomas Tipo 2 , Células Tumorales CultivadasRESUMEN
Type II ribosome inactivating proteins (RIP II) are generally known to induce apoptosis in human cells by the inhibition of protein biosynthesis. Recent data from mistletoe RIP II proteins (eg. mistletoe lectin I; ML1) suggest an additional mode of apoptosis induction through the binding of their lectin part to certain cell surface receptors as is known for some human galectins. In order to clarify this possibility, we used highly sensitive flow cytometric apoptosis assays and mistletoe hololectin subunits of proven purity to show that neither human lymphocytes nor Molt-4 cells undergo apoptosis after treatment with isolated lectin-type B-chains. In contrast to earlier investigations, only the hololectin was able to induce apoptosis in these assays. We conclude that direct apoptosis induction by mistletoe lectins occurs only after uptake of the molecules into the cell due to the action of the ribosome inactivating A-chain.
Asunto(s)
Apoptosis/efectos de los fármacos , Lectinas/toxicidad , Preparaciones de Plantas , Proteínas de Plantas , Toxinas Biológicas/toxicidad , Línea Celular , Citometría de Flujo , Humanos , Técnicas In Vitro , Lectinas/química , Linfocitos/citología , Linfocitos/efectos de los fármacos , Muérdago , Lectinas de Plantas , Plantas Medicinales , Estructura Cuaternaria de Proteína , Proteínas Inactivadoras de Ribosomas Tipo 2 , Ribosomas/efectos de los fármacos , Toxinas Biológicas/química , Toxinas Biológicas/aislamiento & purificaciónRESUMEN
The increased uptake of hexose by mammalian cells is considered to be a general response to stress. Nowadays, mistletoe lectin separated from the extracts of the European mistletoe (Viscum album L.) is often used in adjuvant cancer therapy. The present work studies the effect of the lectin on unirradiated and x-irradiated tumour cells. The response of cultured human lung carcinoma cells (Calu-1) was followed by radioactive glucose uptake as well as by tritiated thymidine incorporation. The cells were maintained either in a complete or a so-called restrictive medium. Slight metabolic changes were found in the restrictive medium but not in the complete one. Mistletoe lectin I at a very low concentration (0.001 ng/mL) increased the glucose uptake and thymidine incorporation. Ionizing radiation (1 Gy) did not influence the hexose uptake but it enhanced the incorporation of thymidine. It seems that the actions of two different factors (mistletoe lectin I and radiation) proved to be rather provoking stress effects for the tumour cells as detected in the restrictive medium.
Asunto(s)
Glucosa/metabolismo , Lectinas/farmacología , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/radioterapia , Muérdago , Preparaciones de Plantas , Proteínas de Plantas , Plantas Medicinales , Timidina/metabolismo , Toxinas Biológicas/farmacología , Terapia Combinada , Humanos , Neoplasias Pulmonares/metabolismo , Lectinas de Plantas , Radiación Ionizante , Proteínas Inactivadoras de Ribosomas Tipo 2 , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/efectos de la radiaciónRESUMEN
Seeds from Acalypha wilkesiana (Euphorbiaceae) are an essential component of a complex plant mixture used empirically by traditional healers in Southwest Nigeria to treat breast tumours and inflammation. To investigate their biological properties, we incubated human lymphocytes and granulocytes with aqueous and ethanolic extracts of A. wilkesiana seeds (AWS). In lymphocytes, we observed an induction of apoptosis and generation of reactive oxygen intermediates (ROI), as measured by the oxidation of hydroethidine, within 2 h, while in granulocytes, an aqueous seed extract induced the oxidative burst and enhanced phagocytosis of Escherichia coli within 10-20 min. In the supernatants of 72-h cultured lymphocytes, AWS induced the release of the pro-inflammatory cytokines tumour necrosis factor-alpha and interleukin-6, and also T-cell-associated cytokines interleukin-5 and interferon-gamma. These preliminary results encourage further investigations of this drug with both cytotoxic and immunomodulating properties.
Asunto(s)
Apoptosis/efectos de los fármacos , Citocinas/metabolismo , Euphorbiaceae/química , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/metabolismo , Células Cultivadas , Escherichia coli/fisiología , Colorantes Fluorescentes/metabolismo , Granulocitos/efectos de los fármacos , Humanos , Interferón gamma/metabolismo , Interleucina-5/metabolismo , Interleucina-6/metabolismo , Linfocitos/efectos de los fármacos , Medicina Tradicional , Nigeria , Oxidación-Reducción , Fagocitosis/efectos de los fármacos , Fenantridinas/metabolismo , Fitoterapia , Estallido Respiratorio/efectos de los fármacos , Factores de TiempoRESUMEN
BACKGROUND: It is unclear whether expression of newly described mitochondrial Apo2.7 molecules (7A6 antigen) is specific for apoptosis or may also occur in necrosis. METHODS: We incubated human lymphocytes with the apoptosis-inducing mistletoe lectin (ML) I and the cell membrane-permeabilizing viscotoxins (VT), and measured cell death-associated changes by flow cytometry. RESULTS: In ML I-treated lymphocytes, Apo2.7 expression and caspase-3 activation was recognized within 24 h. In VT-treated cells, we observed an Apo2.7 expression with low fluorescence level, while active caspase-3 and DNA fragments (TUNEL) were not detected within 24 h. In these cells, caspase-3 activation was recognized 48 h later. As a major subset of ML-treated cells expressing Apo2.7 molecules did not activated caspase-3, while all caspase-3(+) cells did express Apo2.7, one may suggest that the caspase pathway is activated secondarily to mitochondrial events. CONCLUSIONS: Expression of Apo2.7 is sensitive marker of cell death but may not be specific for apoptosis alone as it can be detected also in cells treated with cell membrane-permeabilizing toxins. On the other hand, this expression may be the consequence of an induction of distinct "death signals" resulting in apoptosis later on.
Asunto(s)
Apoptosis , Caspasas/metabolismo , Lectinas/farmacología , Linfocitos/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Preparaciones de Plantas , Proteínas de Plantas , Toxinas Biológicas/farmacología , Caspasa 3 , Células Cultivadas , Activación Enzimática , Citometría de Flujo , Humanos , Etiquetado Corte-Fin in Situ , Linfocitos/metabolismo , Linfocitos/ultraestructura , Microscopía Electrónica , Muérdago , Lectinas de Plantas , Plantas Medicinales , Proteínas Inactivadoras de Ribosomas Tipo 2 , Factores de TiempoRESUMEN
BACKGROUND: Fas ligand (FasL, CD95L) predominantly expressed on activated cytotoxic T cells and NK cells triggers apoptosis in Fas receptor (Apo-1, CD95) positive target cells. We investigated the expression of FasL, Fas and tumor necrosis factor (TNF) receptor 1 (TNF-R1, CD120a) on cultured human lymphocytes and leukemic T and B cells. MATERIALS AND METHODS: Lymphocytes from six healthy individuals, from four patients with chronic lymphocytic T or B cell leukaemia, and leukemic Molt-4 cells were incubated with the apoptosis- inducing mistletoe lectins (ML I and ML III). RESULTS: Incubation of differentiated lymphocytes with the ML resulted in a significant upregulation of FasL in the surviving CD4+ T helper cells, CD8+ cells and CD19+ B cells. Similarly, the TNF receptor expression increased, while the Fas molecule decreased. In contrast, FasL was not induced in leukemic cells. CONCLUSIONS: Apart from a direct induction of apoptosis in response to an inhibition of protein synthesis by the enzymic ML A chain, ML treatment may indirectly induce apoptosis in Fas+ tumour cells through activated FasL+ lymphocytes.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Subgrupos Linfocitarios/efectos de los fármacos , Glicoproteínas de Membrana/biosíntesis , Preparaciones de Plantas , Proteínas de Plantas , Toxinas Biológicas/farmacología , Antígenos CD/biosíntesis , Antígenos CD/genética , Antígenos CD19/análisis , Apoptosis/efectos de los fármacos , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/efectos de los fármacos , Linfocitos T CD8-positivos/metabolismo , Proteína Ligando Fas , Regulación Leucémica de la Expresión Génica/efectos de los fármacos , Humanos , Leucemia de Células B/patología , Leucemia de Células T/patología , Subgrupos Linfocitarios/metabolismo , Glicoproteínas de Membrana/genética , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/genética , Células Madre Neoplásicas/efectos de los fármacos , Células Madre Neoplásicas/metabolismo , Receptores del Factor de Necrosis Tumoral/biosíntesis , Receptores del Factor de Necrosis Tumoral/genética , Receptores Tipo I de Factores de Necrosis Tumoral , Proteínas Inactivadoras de Ribosomas , Proteínas Inactivadoras de Ribosomas Tipo 2 , Linfocitos T/efectos de los fármacos , Linfocitos T/metabolismo , Células Tumorales Cultivadas , Receptor fas/biosíntesis , Receptor fas/genéticaRESUMEN
We analysed mitochondrial alterations in human lymphocytes incubated with toxins exerting RNA and/or protein synthesis/transport inhibitory activity. We found that all toxins known to affect macromolecule synthesis, such as ricin from Ricinus communis, mistletoe lectin I (ML I) from Viscum album, cycloheximide, actinomycin D, and brefeldin A but also the thionins from Viscum album (viscotoxins; VT) generated reactive oxygen intermediates (ROI) and induced expression of newly described mitochondrial membrane proteins Apo2.7, however, with different kinetics. Apart from a rapid permeabilisation of cell membranes by the VT with swelling of mitochondria, loss of their cristae and ROI generation within 2-4 h, the majority of the cells may have received a distinct 'death signal' resulting in an induction of Apo2.7 molecules within 24 h. In contrast, protein synthesis/transport inhibition may signal for apoptosis within 24 h by decreasing distinct 'survival promotors' which remain to be characterised.
Asunto(s)
Linfocitos/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Muérdago/metabolismo , Mitocondrias/metabolismo , Proteínas de Plantas , Plantas Medicinales , Especies Reactivas de Oxígeno/metabolismo , Toxinas Biológicas/farmacología , Anexina A5/metabolismo , Antibióticos Antineoplásicos/farmacología , Apoptosis , Células Cultivadas , Dactinomicina/farmacología , Citometría de Flujo , Humanos , Etiquetado Corte-Fin in Situ , Cinética , Fosfatidilserinas/metabolismo , Factores de TiempoRESUMEN
BACKGROUND: Extracts from European mistletoe (Viscum album L.) are applied in adjuvant cancer treatment, and some components, especially the mistletoe lectins (ML) have been immunologically characterised, but not the thionins, termed viscotoxins (VT). MATERIALS AND METHODS: The influence of the VT on human granulocytes was studied by flow cytometry: E.coli co-stimulated respiratory burst by oxidation of dihydrorhodamine 123 to rhodamine 123 and phagocytosis by ingestion of FITC-labelled E.coli. RESULTS: VT (25 and 250 micrograms/ml), in contrast to ML, significantly enhanced phagocytosis and burst activity. VT-rich mistletoe extracts also exerted significant effects. In addition, E.coli-activated granulocytes positively stain with Annexin-V and propidium iodide only due to 250 micrograms/ml VT incubation, suggesting that at this concentration burst activity was induced by the physiological activity of granulocytes after microbial ingestion and also by cytotoxic effects. CONCLUSION: Viscotoxins exert yet unknown strong immunomodulatory effects on human granulocytes, which might be of benefit for tumour patients, in addition to their cytotoxic properties.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Granulocitos/efectos de los fármacos , Preparaciones de Plantas , Proteínas de Plantas , Toxinas Biológicas/farmacología , Apoptosis/efectos de los fármacos , Granulocitos/fisiología , Humanos , Fagocitosis/efectos de los fármacos , Extractos Vegetales/farmacología , Estallido Respiratorio/efectos de los fármacos , Proteínas Inactivadoras de Ribosomas Tipo 2RESUMEN
The cytotoxic mechanisms of thionins from Viscum album L., the viscotoxins, were investigated in human granulocytes and lymphocytes. The time course of viscotoxin effects indicate accidental cell death, i.e. membrane permeabilization, degradation of cytoplasm and chromatin, swelling of mitochondria with loss of their cristae, and generation of reactive oxygen intermediates within 1-2 h, followed by secondary apoptosis-associated events. The viscotoxin homologue purothionin from whole-wheat flour and viscotoxin B, however, did not induce cell death in cultured lymphocytes. Cytotoxicity of cationic and amphipathic viscotoxin was prevented only by cleavage of its disulphide bridges.
Asunto(s)
Apoptosis/efectos de los fármacos , Linfocitos/efectos de los fármacos , Muérdago/química , Proteínas de Plantas/farmacología , Plantas Medicinales , Especies Reactivas de Oxígeno , Membrana Celular/metabolismo , Humanos , Linfocitos/citología , Linfocitos/fisiología , Potenciales de la Membrana/efectos de los fármacos , Microscopía Electrónica , Mitocondrias/efectos de los fármacos , Mitocondrias/fisiologíaRESUMEN
Anti-mistletoe lectin-1 (ML-1) antibodies are produced during treatment of cancer patients with mistletoe extracts. However, little is known about their ability to recognise distinct epitopes present in mistletoe extracts. To estimate this, ML-1, ML-2 and ML-3 were analysed by Western blot analysis using high titred anti-ML antibody positive sera from cancer patients treated with different mistletoe extracts. In these experiments we could clearly demonstrate that anti-ML antibodies bind to ML-1 A- and B-chains and, in addition, that they recognised a spectrum of other antigens. This kind of immunological response varied from one individual to another and was not influenced by the different mistletoe extracts. Elution studies showed that anti-ML-1 A-chain or B-chain specific antibodies cross-reacted with A- or B-chains of the other lectins indicating homologies between these molecules (probably in the glycosylated side chain). However, the unglycosylated ML-3 A-chain was only detectable by antibodies specific for the ML-3 A-chain. From our data it has to be concluded that different epitopes of the mistletoe extracts are involved in the induction of the humoral immune response during mistletoe therapy and also that cross-reactivity between the different ML exist.
Asunto(s)
Anticuerpos Antiidiotipos/inmunología , Antineoplásicos Fitogénicos/inmunología , Epítopos/inmunología , Muérdago/química , Neoplasias/inmunología , Extractos Vegetales/inmunología , Preparaciones de Plantas , Proteínas de Plantas , Plantas Medicinales , Toxinas Biológicas/inmunología , Adolescente , Adulto , Anciano , Antineoplásicos Fitogénicos/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Proteínas Inactivadoras de Ribosomas Tipo 2RESUMEN
Thionins are small basic peptides found in different plant species, which are known to exert cytotoxic properties. In addition, previous data indicated an activation of human granulocytes by thionins from European mistletoe (viscotoxins, VT). To extend these latter findings, we investigated the influence of VT and from thionins from wheat flour (purothionin) on human granulocytes by flow cytometry and tried to characterise the involved molecular structures and mechanisms. Phagocytosis was determined by incorporation of FITC-labelled Escherichia coli and respiratory burst by oxidation of dihydrorhodamine 123 to rhodamine 123. VT and purothionin significantly enhanced E. coli-stimulated phagocytosis and respiratory burst at 25 and 250 microgram/ml. Phagocytosis of damaged lymphocytes by granulocytes was detected by electron microscopy in the VT-stimulated (100 microgram/ml) but not in the control cultures. The poly-cationic structure of the intact molecule seems to be crucial, as evidenced by comparison of the burst and phagocytosis-enhancing effects induced by other poly-cationic (protamine sulphate, histone, poly-l-arginine, poly-l-lysine) and poly-anionic (poly-l-glutamic acid) peptides, while pore forming due to amphipathic properties seems to be less important. Ca2+ and Mg2+ could not inhibit VT-enhanced phagocytosis and, thus, could not inhibit binding of VT to granulocytes. In addition, verapamil at low concentrations inhibited VT activity, suggesting the involvement of Ca2+ channels for granulocyte activation by the VT. Similarly, thionins and histones in contrast to protamine sulphate induced cell death of granulocytes at 250 microgram/ml as demonstrated by an enhanced release of reactive oxygen intermediates in unstimulated granulocytes. From these data one may suggest that activity of VT is induced by strong unspecific ionic binding, probably followed by specific receptor binding, and thionins exhibit stimulatory and cytotoxic effects on immune cells, which have to be further characterised.